Cantarona, Rolando Y.

HRN: 27-17-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/23/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/23/2025
05/29/2025
IV
500mg
Q8h
Acute Cholecystitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines